- 1630 Connecticut Ave, NW, Suite 500, Washington D.C. 20009
- 202.232.6749
- 202.232.6750
- [email protected]
As there are rapid advancements in innovative HIV treatment, provider education must be timely and relevant to support providers to manage the complexity of patient care — from long-acting agents and injectables to new strategies for managing comorbidities and treatment resistance. Start your HIV innovation journey by enrolling in the free HealthHIV HIV Treatment Innovation™ Certificate Program that features leading experts in the field discussing the latest strategies in HIV treatment and management.
By participating in this free, one-of-a-kind program, experienced providers will:
Providers will receive the latest updates in HIV treatment innovations while establishing a solid foundational understanding of key areas such as comorbidities and the unique needs of older adults, all reinforced through guided patient-case scenarios which feature treatment individualization strategies for enhanced clinical applicability.
If you previously enrolled in a training on eHealthHIV.org, you only need to check your information and update if necessary.
Enroll NowThe update and recertification of the HealthHIV HIV Treatment Innovation Certificate Program was released on November 4, 2024. There are a few key updates to be aware of:
This activity is intended for experienced HIV care providers (HIV and ID specialists), as well as primary care providers and general practitioners (includes MD/DO, NP, PA), nurses, pharmacists, and other professionals involved in the care of PWH.
After completing this activity, the participant should be better able to:
Melissa E. Badowski, PharmD, MPH, FIDSA, FCCP, BCIDP, BCPS, AAHIVP
Clinical Professor, Infectious Diseases Pharmacotherapy, University of Illinois at Chicago, College of Pharmacy
HIV Telemedicine Clinical Specialist, Illinois Department of Corrections, Chicago, IL
This module provides an update on recommended and investigational ARV therapies for optimal HIV care and treatment in HIV care, primary care, and general medicine.
Upon completion of this activity, participants should be able to:
David Alain Wohl, MD
Professor of Medicine in the Division of Infectious Diseases, University of North Carolina School of Medicine
Co-Principal Investigator, Global UNC Infectious Diseases Clinical Trial Unit
Site Leader, HIV Prevention and Treatment Clinical Trials Unit, Chapel Hill, NC
This module provides considerations for managing and preventing common comorbidities, co-infections and opportunistic infections among PWH.
Upon completion of this activity, participants should be able to:
Jonathan S. Appelbaum, MD, FACP, AAHIVS
Professor Emeritus, Florida State University College of Medicine
Medical Director, Care Point Health and Wellness, Tallahassee, FL
This module provides considerations for managing HIV care among older adults and long-term HIV survivors.
Upon completion of this activity, participants should be able to:
Kathleen A. McManus, MD, MSc, FIDSA
Associate Professor of Medicine, Division of Infectious Diseases and International Health, University of Virginia School of Medicine
Medical Director, UVA Ryan White HIV Clinic, Charlottesville, VA
This module provides evidence-based HIV treatment optimization strategies for delivering quality HIV care among key populations.
Upon completion of this activity, participants should be able to:
Monica Gandhi, MD, MPH
Professor of Medicine, Associate Chief in the Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco
Medical Director, Ward 86 HIV Clinic at San Francisco General Hospital, San Francisco, CA
This module provides information on the latest strategies for managing treatment of patients with HIV drug resistance.
Upon completion of this activity, participants should be able to:
Asa E. Radix, MD, PhD, MPH, FIDSA
Associate Professor of Clinical Epidemiology, Columbia University, Mailman School of Public Health
Infectious Disease/HIV Specialist, Callen-Lorde Community Health Center, New York, NY
This module offers comprehensive patient cases that require learners to apply knowledge from Modules 1-5 in case-based scenarios.
Upon completion of this activity, participants should be able to:
All modules are certified and participants can earn up to 5.5 Credits/Contact Hours (CME, MOC, NCPD, AAPA, CPE) for completion of the certificate.
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc. and HealthHIV. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Medical Learning Institute, Inc. (MLI) designates the modules within this enduring material for the following AMA PRA Category 1 Credits™ :
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participation information will be shared through the ACCME’s Program and Activity Reporting System (PARS).
Successful completion of this nursing continuing professional development activity will be awarded the following contact hour and contact hour in the area of pharmacology.
Module | NCPD Contact Hour | Pharmacology Contact Hour |
---|---|---|
Module 1: Innovations in Antiretroviral Therapies to Optimize HIV Treatment | up to 1.0 | 0.5 |
Module 2: Management of Common Comorbidities for People Living with HIV | up to 1.0 | 1.0 |
Module 3: Considerations in the Management of HIV in Older Adults | up to 1.0 | 0.75 |
Module 4: Improving Health Equity in HIV Management | up to 1.0 | None |
Module 5: Management of Treatment-Experienced Patients with HIV Drug Resistance | up to 1.0 | 1.0 |
Module 6: Applying HIV Treatment Individualization in Patient Case Scenarios | up to 0.5 | 0.5 |
Medical Learning Institute, Inc. designates this knowledge-based continuing education activity for the following contact hour and CEU of the Accreditation Council for Pharmacy Education.
Module | CPE Contact Hour | UAN Number |
---|---|---|
Module 1: Innovations in Antiretroviral Therapies to Optimize HIV Treatment | up to 1.0 (0.1 CEU) | JA0007322-9999-24-085-H01-P |
Module 2: Management of Common Comorbidities for People Living with HIV | up to 1.0 (0.1 CEU) | JA0007322-9999-24-086-H01-P |
Module 3: Considerations in the Management of HIV in Older Adults | up to 1.0 (0.1 CEU) | JA0007322-9999-24-087-H01-P |
Module 4: Improving Health Equity in HIV Management | up to 1.0 (0.1 CEU) | JA0007322-9999-24-088-H01-P |
Module 5: Management of Treatment-Experienced Patients with HIV Drug Resistance | up to 1.0 (0.1 CEU) | JA0007322-9999-24-089-H01-P |
Module 6: Applying HIV Treatment Individualization in Patient Case Scenarios | up to 0.5 (0.05 CEU) | JA0007322-9999-24-090-H01-P |
This program has been supported by an independent educational grant from Gilead Sciences, Inc.
Melissa E. Badowski, PharmD, MPH, FCCP, FIDSA, BCIDP, BCPS, AAHIVP
University of Illinois Chicago
Chicago, IL
Melissa E. Badowski, PharmD, MPH, FCCP, FIDSA, BCIDP, BCPS, AAHIVP, has no relevant financial relationships with ineligible companies to disclose for this educational activity.
David A. Wohl, MD
UNC School of Medicine – Institute for Global Health and Infectious Diseases
Chapel Hill, NC
David A. Wohl, MD, has a financial interest/relationship or affiliation in the form of:
Jonathan S. Appelbaum, MD, FACP, AAHIVS
Florida State University College of Medicine
Care Point Health and Wellness
Tallahassee, FL
Jonathan S. Appelbaum, MD, FACP, AAHIVS, has a financial interest/relationship or affiliation in the form of:
Kathleen A. McManus, MD, MSc, FIDSA
University of Virginia, School of Medicine
Charlottesville, VA
Kathleen A. McManus, MD, MSc, has a financial interest/relationship or affiliation in the form of:
Monica Gandhi, MD, MPH
University of San Francisco – School of Medicine
San Francisco, CA
Monica Gandhi, MD, MPH, has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Asa E. Radix, MD, PhD, MPH, FIDSA
Columbia University Mailman – School of Public Health
New York, NY
Asa E. Radix, MD, PhD, MPH, FACP, has no relevant financial relationships with ineligible
companies to disclose for this educational activity.
All of the relevant financial relationships of individuals for this activity have been mitigated.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your ABIM ID number, DOB (MM/DD), and a score of 70% or higher is needed to obtain MOC credit.
For Pharmacists, MLI will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute, Inc. or any of its partners, providers, and/or supporters.
If you are a US-based provider, you may be asked to create and/or update your profile before enrolling. Please be sure all required fields are completed in the profile form before selecting submit. If you are a non-US provider, and are having trouble accessing a course, please know that our learning management system will soon be configured to accommodate learners from other countries outside the US.
We are working to ensure support for international learners, and will provide more information about accessing our courses soon. In the meantime, if you’d like to access courses or have questions about access, please email [email protected] or [email protected].
Please ensure you have completed a course’s post-test (if applicable) and evaluation survey before choosing the activity to obtain your certificate of completion. Your certificate of completion may take a few days to arrive by email, and it may be directed to a junk or spam folder.
You may access this program, and all of HealthHIV’s certification programs, at no cost.
© Copyright 2024 HealthHIV. All rights reserved.